{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T19:17:28Z","timestamp":1648667848342},"reference-count":4,"publisher":"Pharmaceutical Society of Japan","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["YAKUGAKU ZASSHI"],"published-print":{"date-parts":[[2020,6,1]]},"DOI":"10.1248\/yakushi.19-00253-2","type":"journal-article","created":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T22:10:09Z","timestamp":1590963009000},"page":"763-766","source":"Crossref","is-referenced-by-count":0,"title":["Implementation of the Latest Scientific Knowledge\/Technologies and Activities for International Harmonisation of the Japanese Pharmacopoeia"],"prefix":"10.1248","volume":"140","author":[{"given":"Tsuyoshi","family":"Ando","sequence":"first","affiliation":[{"name":"Division of Pharmacopoeia and Standards for Drugs, Office of Review Management, Pharmaceuticals and Medical Devices Agency"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Osawa","sequence":"additional","affiliation":[{"name":"Office of Non-clinical and Clinical Compliance, Pharmaceuticals and Medical Devices Agency"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Economic Affairs Division, Health Policy Bureau, Ministry of Health, Labour and Welfare, \u201cKohatsuiyakuhin Shiyosokushin Roadmap Kensho Kentou Jigyou Houkokusho,\u201d March 2019, p. 19."},{"key":"2","unstructured":"2) Pharmaceutical Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labour and Welfare, \u201cIyakuhin no Gensofujunbutsu Guideline nitsuite,\u201d 30 September, 2015."},{"key":"3","unstructured":"3) Pharmacopoeial Discussion Group (PDG) Implementation of General Chapters: \u3008https:\/\/www.pmda.go.jp\/rs-std-jp\/standards-development\/jp\/0020.html\u3009, Pharmaceuticals and Medical Devices Agency Web, cited 13 October, 2019."},{"key":"4","unstructured":"4) Pharmacopoeial Discussion Group (PDG) Implementation of Excipient Monographs: \u3008https:\/\/www.pmda.go.jp\/rs-std-jp\/standardsdevelopment\/jp\/0020.html\u3009, Pharmaceuticals and Medical Devices Agency Web, cited 13 October, 2019."}],"container-title":["YAKUGAKU ZASSHI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yakushi\/140\/6\/140_19-00253-2\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T03:26:04Z","timestamp":1591413964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yakushi\/140\/6\/140_19-00253-2\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":4,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/yakushi.19-00253-2","relation":{},"ISSN":["0031-6903","1347-5231"],"issn-type":[{"value":"0031-6903","type":"print"},{"value":"1347-5231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]}}}